Literature DB >> 30897229

Overexpression of cyclin-dependent kinase 4 protein in extramammary Paget's disease.

Kazumi Urata1, Ikko Kajihara1, Tselmeg Mijiddorj Myangat1, Yukino Tasaki1, Saki Otsuka-Maeda1, Soichiro Sawamura1, Saori Kanazawa-Yamada1, Ryoko Sakamoto1, Katsunari Makino1, Jun Aoi1, Toshikatsu Igata1, Takamitsu Makino1, Shinichi Masuguchi1, Satoshi Fukushima1, Masatoshi Jinnin1, Hironobu Ihn1.   

Abstract

Cyclin-dependent kinase 4 and 6 (CDK4/6) plays an important role in cell cycle progression, and the CDK4/6-cyclin D1 complex controls the cell cycle transition from G1 phase to S phase. CDK4 is enhanced in several types of cancers and CDK4/6 inhibitors attenuate the proliferation of several types of cancer in vitro/in vivo. The purpose of our study was to investigate the expression pattern of CDK4 and evaluate its clinical importance in extramammary Paget's disease (EMPD). Almost all EMPD tissues were positive for CDK4, and metastatic lesions had a similar immunostaining intensity to primary lesions. In addition, CDK4 protein levels were positively correlated with those of cyclin D1 protein. Taken together, CDK4 may assume a crucial role in EMPD progression.
© 2019 Japanese Dermatological Association.

Entities:  

Keywords:  CDK4; cyclin D1; immunohistochemistry; metastasis; therapeutic target

Mesh:

Substances:

Year:  2019        PMID: 30897229     DOI: 10.1111/1346-8138.14858

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Yoshinao Oda; Takamichi Ito
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

2.  Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.

Authors:  Shinya Kitamura; Teruki Yanagi; Takuya Maeda; Hideyuki Ujiie
Journal:  Cancer Sci       Date:  2021-12-13       Impact factor: 6.716

3.  Efficacy of Abemaciclib in the Management of Refractory Metastatic Extramammary Paget's Disease.

Authors:  Gary W Takahashi; John Vetto; Justin J Leitenberger; Arthur Hung
Journal:  Cureus       Date:  2022-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.